Cited by 1,428HIV/AIDS Research and InterventionsMedication Adherence and ComplianceHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments

Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., PATIENT CARE COMMITTEE & ADHERENCE·2000·AIDS Care

DOI 10.1080/09540120050042891

Open this paper in CoChat — free account

Abstract

This paper describes the AACTG Adherence Instruments, which are comprised of two self-report questionnaires for use in clinical trials conducted by the Adult AIDS Clinical Trials Group (AACTG). The questionnaires were administered to 75 patients at ten AACTG sites in the USA. All patients were taking combination antiretroviral therapy (ART), including at least one protease inhibitor. Eleven per cent of patients reported missing at least one dose the day before the interview, and 17% reported missing at least one dose during the two days prior. The most common reasons for missing medications included 'simply forgot' (66%) and a number of factors often associated with improved health, including being busy (53%), away from home (57%) and changes in routine (51%). Less adherent patients reported lower adherence self-efficacy (p = 0.006) and were less sure of the link between non-adherence and the development of drug resistance (p = 0.009). They were also more likely to consume alcohol, to be employed outside the home for pay and to have enrolled in clinical trials to gain access to drugs (all p < 0.05). Twenty-two per cent of patients taking drugs requiring special instructions were unaware of these instructions. Each questionnaire took approximately ten minutes to complete. Responses to the questionnaires were favourable. These questionnaires have been included in six AACTG clinical trials to date and have been widely disseminated to investigators both in the USA and abroad.

Integrity signals

Registry

Crossref · 10.1080/09540120050042891

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381301 · Cited by 9,393
Survey Research Methods.
Hesselbart, S., & Fowler, F. J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288598 · Cited by 4,767
Compliance in Health Care
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 1,627
Age and Depression
Mirowsky, J., & Ross, C. E. (1992) · Journal of Health and Social Behavior · doi:10.2307/2137349 · Cited by 856
Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease Inhibitors
Hecht, F. M., Grant, R. M., Petropoulos, C. J., Dillon, B. A., Chesney, M. A., Tian, H., Hellmann, N. S., Bandrapalli, N. I., Digilio, L., Branson, B. M., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390504 · Cited by 443
Self-citation
Patient Compliance and Drug Failure in Protease Inhibitor Monotherapy
Vanhove, G. F. (1996) · JAMA · doi:10.1001/jama.1996.03540240033024 · Cited by 193
Protease Inhibitors in the Homeless
Bangsberg, D. R. (1997) · JAMA · doi:10.1001/jama.1997.03550010077044 · Cited by 150
Compliance in clinical trials
Besch, C. L. (1995) · AIDS · doi:10.1097/00002030-199501000-00001 · Cited by 148
Predictors of patient adherence: Patient characteristics.
Dunbar, J. (1990) · Cited by 83

Show all 12 references

Sorted by citations

Items 801–900 of 1,001

Community outreach with weekly delivery of anti-retroviral drugs compared to cognitive-behavioural health care team-based approach to improve adherence among indigent women newly starting HAART
Visnegarwala, F., Rodriguez-Barradass, M. C., Graviss, E. A., Caprio, M., Nykyforchyn, M., & Laufman, L. E. (2006) · AIDS Care · doi:10.1080/09540120500162155 · Cited by 21
Correlates of Antiretroviral and Antidepressant Adherence Among Depressed HIV-Infected Patients
Bottonari, K. A., Tripathi, S. P., Fortney, J. C., Curran, G. M., Rimland, D., Rodriguez‐Barradas, M. C., Gifford, A. L., & Pyne, J. M. (2012) · AIDS Patient Care and STDs · doi:10.1089/apc.2011.0218 · Cited by 20
Self-citation
The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi
Kim, M. H., Tembo, T. A., Mazenga, A. C., Yu, X., Myer, L., Sabelli, R. A., Flick, R. J., Hartig, M., Wetzel, E., Simon, K., et al. (2020) · Trials · doi:10.1186/s13063-020-4131-8 · Cited by 20
One-, Two-, and Three-Class Resistance among HIV-Infected Patients on Antiretroviral Therapy in Private Care Clinics: Mumbai, India
Gupta, A., Saple, D. G., Nadkarni, G. N., Shah, B. B., Vaidya, S., Hingankar, N. K., Chaturbhuj, D. N., Deshmukh, P., Walshe, L., Hudelson, S. E., et al. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2009.0102 · Cited by 20
Educational attainment and response to HAART during initial therapy for HIV-1 infection.
Marc, L. G., Testa, M., Walker, A., Robbins, G. K., Shafer, R., Anderson, N., & Berkman, L. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.04.009 · Cited by 21
Adherencia al tratamiento en la infección por VIH/SIDA. Consideraciones teóricas y metodológicas para su abordaje
Arévalo, M. T. V., Salazar, I. C., & Sánchez, D. C. (2008) · Dialnet (Universidad de la Rioja) · Cited by 20
Psychosocial factors in adherence to antiretroviral therapy among HIV-positive people who use drugs.
Lee, W. K., Milloy, M., Walsh, J. C., Nguyen, P., Wood, E., & Kerr, T. H. (2015) · Health Psychology · doi:10.1037/hea0000310 · Cited by 20
Complementary and Alternative Medicine Use for HIV Management in the State of Florida: Medical Monitoring Project
Chichetto, N. E., Okafor, C. N., Harman, J. S., Canidate, S. S., Cook, C. L., & Cook, R. L. (2016) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2016.0190 · Cited by 20
Sub-optimal adherence to combination anti-retroviral therapy and its associated factors according to self-report, clinician-recorded and pharmacy-refill assessment methods among HIV-infected adults in Addis Ababa
Mekuria, L. A., Prins, J. M., Worku, A., Sprangers, M. A. G., & Nieuwkerk, P. T. (2016) · AIDS Care · doi:10.1080/09540121.2016.1234681 · Cited by 20
Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV
Garvie, P. A., Brummel, S. S., Allison, S. M., Malee, K., Mellins, C. A., Wilkins, M. L., Harris, L. L., Patton, E. D., Chernoff, M. C., Rutstein, R. M., et al. (2017) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001573 · Cited by 20
Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART
Been, S. K., Yildiz, E., Nieuwkerk, P. T., Pogány, K., van de Vijver, D. A. M. C., & Verbon, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186912 · Cited by 20
Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia
Idrisov, B. T., Lunze, K., Cheng, D. M., Blokhina, E. A., Gnatienko, N., Quinn, E. K., Bridden, C. L., Walley, A. Y., BRYANT, K. J., Lioznov, D. A., et al. (2017) · Addiction Science & Clinical Practice · doi:10.1186/s13722-017-0098-5 · Cited by 20
“Covariates In the analysis of the primary outcome (linkage to care), the following potential confounders were included based on the literature and our clinical knowledge: age, gender, education, marital status, income, social support [31], depressive symptoms (Center for Epidemiologic Studies Depression Scale [CES-D])…”
Method
Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV
Omonaiye, O., Kusljic, S., Nicholson, P., Mohebbi, M., & Manias, E. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.02.014 · Cited by 20
Language, Literacy, and Communication Regarding Medication in an Anticoagulation Clinic: Are Pictures Better Than Words?
Schillinger, D., Machtinger, E. L., Wang, F. M., Chen, L.-L., Win, K., Palácios, J., Rodriguez, M., & Bindman, A. B. (2005) · Defense Technical Information Center (DTIC) · Cited by 20
Adherence and Viral Suppression Among Infants and Young Children Initiating Protease Inhibitor-based Antiretroviral Therapy
Teasdale, C. A., Abrams, E. J., Coovadia, A. H., Strehlau, R., Martens, L., & Kuhn, L. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31827e84ba · Cited by 20
“Questionnaires about barriers to adherence, such as the caregiver forgetting to give medication or the child refusing to take the treatment, have also been developed for assessing adherence in clinical trials.(15) pill counts of returned medication, or weights of returned syrups for young children, can also be used to…”
Background
Changes in Stress, Substance Use and Medication Beliefs are Associated with Changes in Adherence to HIV Antiretroviral Therapy
French, T., Tesoriero, J. M., & Agins, B. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9762-4 · Cited by 20
Results of Antiretroviral Treatment Interruption and Intensification in Advanced Multi-Drug Resistant HIV Infection from the OPTIMA Trial
Holodniy, M., Brown, S. T., Cameron, D. W., Kyriakides, T. C., Angus, B., Babiker, A. G., Singer, J., Owens, D. K., Anis, A. H., Goodall, R. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014764 · Cited by 20
“Medication compliance was determined at each follow-up visit using an assessment tool adopted from the AIDS Clinical Trials Group adherence questionnaire [27].”
Method
REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care
Howarth, A., Apea, V., Michie, S., Stephen Morris, A., Sachikonye, M., Mercer, C. H., Evans, A. M., Delpech, V., Sabin, C. A., & Burns, F. M. (2017) · Health Services and Delivery Research · doi:10.3310/hsdr05130 · Cited by 20
Validity assessment of the PROMIS fatigue domain among people living with HIV
Gibbons, L. E., Fredericksen, R. J., Batey, D. S., Dant, L., Edwards, T. C., Mayer, K. H., Mathews, W. C., Morales, L. S., Mugavero, M. J., Yang, F. M., et al. (2017) · AIDS Research and Therapy · doi:10.1186/s12981-017-0146-y · Cited by 20
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353
Nyaku, A. N., Zheng, L., Gulick, R. M., Olefsky, M., Berzins, B., Wallis, C. L., Godfrey, C. C., Sax, P. E., Acosta, E. P., Haas, D. W., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky564 · Cited by 19
“I've Learned to Value Myself More”: Piloting an Adapted Multilevel Intervention for Transgender Women Sex Workers Living with HIV in the Dominican Republic
Barrington, C., Davis, D. A., Gómez, H., Donastorg, Y., Pérez, M., & Kerrigan, D. L. (2020) · Transgender Health · doi:10.1089/trgh.2020.0058 · Cited by 19
Pharmacist-led counselling intervention to improve antiretroviral drug adherence in Pakistan: a randomized controlled trial
Chatha, Z. F., Rashid, U., Olsen, S., Din, F. U., Khan, A., Nawaz, K., Gan, S. H., & Khan, G. M. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05571-w · Cited by 23
Validating the relationship between service quality, patient sensitivity and experience towards medical applications using SERVQUAL
Malathi, A. C. J., & Jasim, K. M. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104883 · Cited by 26
Domains of Life Satisfaction Among Patients Living With HIV: A Factor Analytic Study of the Quality of Life Inventory
O’Cleirigh, C. M., & Safren, S. A. (2006) · AIDS and Behavior · doi:10.1007/s10461-005-9027-9 · Cited by 19
“The AIDS Clinical Trials Group (ACTG) Adherence Questionnaire (Chesney et al., 2000) asks participants to record the number of pills prescribed each day and to report the number of pills taken each day over a specified time period.”
Method
Profiles of Risk Among HIV-Infected Youth in Clinic Settings
Fernandez, M. I., Huszti, H. C., Wilson, P. A., Kahana, S. Y., Nichols, S., Gonin, R., Xu, J., & Kapogiannis, B. G. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0876-y · Cited by 19
Depot Medroxyprogesterone Acetate in Combination with a Twice-Daily Lopinavir-Ritonavir-Based Regimen in HIV-Infected Women Showed Effective Contraception and a Lack of Clinically Significant Interactions, with Good Safety and Tolerability: Results of the ACTG 5283 Study
Luque, A. E., Cohn, S. E., Park, J., Cramer, Y. S., Weinberg, A., Livingston, E. G., Klingman, K. L., Aweeka, F. T., & Watts, D. H. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04701-14 · Cited by 19
Use of Unannounced Telephone Pill Counts to Measure Medication Adherence Among Adolescents and Young Adults Living With Perinatal HIV Infection
Raymond, J., Bucek, A., Dolezal, C. L., Warne, P. A., Benson, S. M., Abrams, E. J., Elkington, K. S., Kalichman, S. C., Kalichman, M. O., & Mellins, C. A. (2017) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx064 · Cited by 19
Rates and predictors of adherence and retention for antiretroviral therapy among HIV-positive adults in Enugu, Nigeria
Chime, O. H. (2019) · Malawi Medical Journal · doi:10.4314/mmj.v31i3.7 · Cited by 19
HIV Clients as Agents for Prevention: A Social Network Solution
Ssali, S., Wagner, G. J., Tumwine, C., Nannungi, A., & Green, H. D. (2012) · AIDS Research and Treatment · doi:10.1155/2012/815823 · Cited by 19
Treating depression in HIV-positive patients affects adherence
Moosa, M. Y. H., & Jeenah, F. Y. (2012) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v13i3.128 · Cited by 21
Development of an Electronic Medical Record-Based Clinical Decision Support Tool to Improve HIV Symptom Management
Nader, C. M., Tsevat, J., Justice, A. C., Mrus, J. M., Levin, F. L., Kozal, M. J., Mattocks, K. M., Farber, S. J., Rogers, M. L., Erdos, J., et al. (2009) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0209 · Cited by 19
Optimizing the effects of stress management interventions in HIV.
O’Cleirigh, C. M., & Safren, S. A. (2008) · Health Psychology · doi:10.1037/a0012607 · Cited by 19
“The relationship between stress and suboptimal medication adherence in HIV is also demonstrated (e.g., Chesney et al., 2000; Mugavero et al., 2006; O’Cleirigh, Ironson, & Smits, 2007; Vanable, Carey, Blair, & Littlewood, 2006).”
Background
Factors Influencing Adherence to Molecular Therapies in Haematology‐Oncology Outpatients
Larizza, M. A., Dooley, M. J., Stewart, K., & Kong, D. C. M. (2006) · Journal of Pharmacy Practice and Research · doi:10.1002/j.2055-2335.2006.tb00584.x · Cited by 19
The Information and Motivation and Behavioral Skills Model of ART Adherence among HIV-Positive Adults in Mexico
Torija, C. S. T., Vazquéz, G. V., Montijo, S. S. R., & Romo, L. D. L. E. (2015) · Journal of the International Association of Providers of AIDS Care (JIAPAC) · doi:10.1177/2325957415581903 · Cited by 19
Antiretroviral adherence and treatment outcomes among adult Ethiopian patients
Bezabhe, W., Chalmers, L., Bereznicki, L., Gee, P., & Peterson, G. (2016) · AIDS Care · doi:10.1080/09540121.2016.1139039 · Cited by 19
“Dose and time adherence was measured using the modified AIDS Clinical Trial Group (ACTG) selfreported adherence questionnaire (Chesney et al., 2000).”
MethodResult
The HIV Medication Self-Reported Nonadherence Reasons (SNAR) Index and Its Underlying Psychological Dimensions
Schönnesson, L. N., Ross, M. W., & Williams, M. L. (2004) · AIDS and Behavior · doi:10.1023/b:aibe.0000044076.98833.64 · Cited by 19
Acceptability and factors associated with willingness to receive short messages for improving antiretroviral therapy adherence in China
Xiao, Y., Ji, G., Tian, C.-C., Li, H., Biao, W., & Hu, Z. (2014) · AIDS Care · doi:10.1080/09540121.2013.869540 · Cited by 18
“Forgetting was one major reason for missing medication (Chesney et al., 2000).”
Background
HIV-1 Amino Acid Changes Among Participants With Virologic Failure: Associations With First-line Efavirenz or Atazanavir Plus Ritonavir and Disease Status
Mollan, K. R., Daar, E. S., Sax, P. E., Balamane, M., Collier, A. C., Fischl, M. A., Lalama, C. M., Bosch, R. J., Tierney, C., & Katzenstein, D. A. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis613 · Cited by 18
The Intersection of Inequitable Gender Norm Endorsement and HIV Stigma: Implications for HIV Care Engagement for Men in Ugandan Fishing Communities
Sileo, K. M., Wanyenze, R. K., Mukasa, B., Musoke, W., & Kiene, S. M. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03176-1 · Cited by 18
“In the multivariate analyses for missed ARVs, a statistically significant interaction was observed between internalized HIV stigma and inequitable gender norm endorsement on missed ARV doses (AOR 5.32, 95% CI 2.60–10.86, p 0.001).”
MethodInfluential
Using Interactive Web-Based Screening, Brief Intervention and Referral to Treatment in an Urban, Safety-Net HIV Clinic
Rose, C. D., Cuca, Y. P., Kamitani, E., Eng, S., Zepf, R., Draughon, J. E., & Lum, P. J. (2015) · AIDS and Behavior · doi:10.1007/s10461-015-1078-y · Cited by 18
“Using the Adult AIDS Clinical Trials Group (AACTG) Medication Adherence 30-day Visual Analog Scale (VAS), participants were asked to estimate how often they took their medications as prescribed in the past 30 days, on a scale ranging from 0 to 100 % [23].”
Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia
Laisaar, K.-T., Uusküla, A., Sharma, A., DeHovitz, J. A., & Amico, K. R. (2013) · AIDS Care · doi:10.1080/09540121.2013.764393 · Cited by 18
Engagement with Care, Substance Use, and Adherence to Therapy in HIV/AIDS
Nicholas, P. K., Willard, S. S., Thompson, C. M., Dawson-Rose, C. S., Corless, I. B., Wantland, D. J., Sefcik, E. F., Nokes, K. M., Kirksey, K. M., Hamilton, M. J., et al. (2014) · AIDS Research and Treatment · doi:10.1155/2014/675739 · Cited by 18
Coping Self-Efficacy as a Predictor of Adherence to Antiretroviral Therapy in Men and Women Living with HIV in Kenya
Kamau, T., Olson, V., Zipp, G., & Clark, M. (2011) · AIDS Patients Care and STDs · doi:10.1089/apc.2011.0125 · Cited by 22
Pre-exposure prophylaxis for HIV infection: how antiretroviral pharmacology helps to monitor and improve adherence
Blumenthal, J. S., & Haubrich, R. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.812072 · Cited by 18
“Various self-report adherence questionnaires have been used to assess recent ART adherence including the AIDS Clinical Trials Group four-day recall Instrument [39], the Visual Analog Scale [40], the Likert scale [41,42], and the Morisky Self-reported Medication Taking Scale [43].”
Method
What Time is it? Adherence to Antiretroviral Therapy in Ethiopia
Tiruneh, Y. M., & Wilson, I. B. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1322-0 · Cited by 18
“’s instrument for adherence to antiretroviral medication [43].”
Brief Exposure to Cognitive Behavioral Therapy Reduces Side-Effect Symptoms in Patients on Antiretroviral Therapy
Doerfler, R., & Goodfellow, L. M. (2016) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2016.02.010 · Cited by 18
“Adherence was measured using VAS (Giordano, Guzman, Clark, Charlebois, & Bangsberg, 2004) and 3-day recall of medication doses missed (Chesney et al., 2000).”
BackgroundMethodInfluential
Association between depressive symptoms, CD4 count and HIV viral suppression among HIV-HCV co-infected people
Aibibula, W., Cox, J., Hamelin, A.-M., Moodie, E. E. M., Anema, A., Klein, M. B., Brassard, P., & The Canadian Co-infection Cohort Investigators (2018) · AIDS Care · doi:10.1080/09540121.2018.1431385 · Cited by 18
“The short version of the CES-D scale has good predictive accuracy (kappa = 0.97) when compared to the original full scale (Andresen et al., 1994), and has been validated in the Canadian context (Zhang et al., 2012). cART adherence was measured using items from the AIDS Clinical Trials Group (ACTG) Adherence Questionna…”
MethodInfluential
Understanding the impact of a syndemic on the use of pre-exposure prophylaxis in a community-based sample of behaviorally PrEP-eligible BMSM in the United States
Chandler, C. J., Bukowski, L. A., Matthews, D. D., Hawk, M. E., Marković, N., Stall, R. D., & Egan, J. E. (2019) · AIDS Care · doi:10.1080/09540121.2019.1659921 · Cited by 19
“Additionally, some of the behaviors that have been reported by BMSM using PrEP have been associated with non-adherence among MSM living with HIV (Chesney et al., 2000).”
Background
‘Mothers moving towards empowerment’ intervention to reduce stigma and improve treatment adherence in pregnant women living with HIV in Botswana: study protocol for a pragmatic clinical trial
Poku, O. B., Foster, A. H., Entaile, P., Misra, S., Mehta, H. T., Rampa, S., Goodman, M. S., Arscott‐Mills, T., Eschliman, E. L., Jackson, V., et al. (2020) · Trials · doi:10.1186/s13063-020-04676-6 · Cited by 18
“Follow-Up Questionnaire, which asks participants details about their HIV medication use patterns over the last 4 days and any reasons for non-adherence [94].”
Background
Patient acceptability and usability of a self-administered electronic patient-reported outcome assessment in HIV care: relationship with health behaviors and outcomes
Fredericksen, R. J., Harding, B. N., Ruderman, S. A., McReynolds, J., Barnes, G., Lober, W. B., Fitzsimmons, E., Nance, R. M., Whitney, B. M., Delaney, J. A., et al. (2020) · AIDS Care · doi:10.1080/09540121.2020.1845288 · Cited by 18
HIV Treatment Adherence Measurement and Reporting Concordance in Youth with Perinatally Acquired HIV Infection and Their Caregivers
Evans, S. D., Mellins, C. A., Leu, C., Warne, P. A., Elkington, K. S., Dolezal, C. L., Santamaria, E. K., WIZNIA, A. A., Bamji, M., Jurgrau, A., et al. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2014.0058 · Cited by 18
Antiretroviral Therapy Adherence: Testing a Social Context Model Among Black Men Who Use Illicit Drugs
Phillips, J. C. (2010) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2010.07.008 · Cited by 19
“Research spanning multiple populations has identified several factors that contribute toward an individual’s experience with ART and the ability to consistently adhere to a prescribed regimen (Chesney et al., 2000; Oggins, 2003; Ware et al., 2005).”
Background
Intention to adhere to HIV treatment: a patient‐centred predictor of antiretroviral adherence
Nelsen, A. J., Gupta, S., Trautner, B. W., Petersen, N., Garza, A., Giordano, T. P., Naik, A. D., & Rodriguez‐Barradas, M. (2013) · HIV Medicine · doi:10.1111/hiv.12032 · Cited by 18
Pharmacist counseling to cardiac patients in Israel prior to discharge from hospital contribute to increasing patient's medication adherence closing gaps and improving outcomes
Bisharat, B., Hafi, L., Baron-Epel, O. B., Armaly, Z., & Bowirrat, A. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-34 · Cited by 18
“Medication complexity includes items on frequency, special instructions and behaviors related to medications, and other difficulties encountered [12-15].”
Background
Compassionate love predicts long-term survival among people living with HIV followed for up to 17 years
Ironson, G. H., Kremer, H., & Lucette, A. (2017) · The Journal of Positive Psychology · doi:10.1080/17439760.2017.1350742 · Cited by 19
“The interviewer-administered AIDS Clinical Trial Group adherence measure (Chesney et al., 2000) yielded the percentage of missed antiretrovirals over three days (averaged over the first five years).”
Method
Health-related barriers to employment among people with HIV/AIDS
Razzano, L. A., & Hamilton, M. M. (2005) · Journal of Vocational Rehabilitation · doi:10.3233/jvr-2005-00286 · Cited by 18
“Items regarding beneﬁts and entitlements were adapted from the Employment Intervention Demonstration Program (EIDP), a federally-funded multisite study of employment [9] and the AIDS Clinical Trials Group [8].”
Evaluation of multiple measures of antiretroviral adherence in the Eastern European country of Georgia
Chkhartishvili, N., Rukhadze, N., Svanidze, M., Sharvadze, L., DeHovitz, J. A., Tsertsvadze, T., McNutt, L., & del Rı́o, C. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.18885 · Cited by 17
Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy
Hanna, D. B., Jung, M., Xue, X., Anastos, K., Cocohoba, J. M., Cohen, M. H., Golub, E. T., Hessol, N. A., Levine, A. M., Wilson, T. E., et al. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0143 · Cited by 17
Investigating the impact of a community home-based care on mental health and anti-retroviral therapy adherence in people living with HIV in Nepal: a community intervention study
Pokhrel, K. N., Sharma, V. D., Pokhrel, K. G., Neupane, S. R., Mlunde, L. B., Poudel, K. C., & Jimba, M. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3170-1 · Cited by 17
Self-Compassion in PLWH: Less Internalized Shame and Negative Psychosocial Outcomes
Williams, S. L., Fekete, E. M., & Skinta, M. D. (2019) · Behavioral Medicine · doi:10.1080/08964289.2019.1659749 · Cited by 17
“were measured with symptom items from the ACTG Adherence Baseline Questionnaire.(50) Participants”
Method
Sociodemographic and psychosocial predictors of longitudinal antiretroviral therapy (ART) adherence among first-time ART initiators in Cape Town, South Africa
Davis, A., Pala, A. N., Nguyen, N., Robbins, R. N., Joska, J. A., Gouse, H., Mellins, C. A., Myer, L., Henry, M., Leu, C. S., et al. (2020) · AIDS Care · doi:10.1080/09540121.2020.1798336 · Cited by 17
“…HIV Adherence Self-Efficacy Scale (HIVASES) to assess participants’ confidence in their own ability to adhere to a treatment plan (Cronbach’s α = 0.88) (Chesney et al., 2000; Johnson et al., 2007); Beliefs About Medicines Questionnaire (BMQ) (Horne et al., 1999) to assess positive (α = 0.77) and…”
BackgroundInfluential
Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment
Ellsworth, G. B., Burke, L. A., Wells, M. T., Mishra, S. C., Caffrey, M., Liddle, D. G., Madhava, M. L., O'Neal, C., Anderson, P. L., Bushman, L. R., et al. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002519 · Cited by 18
“On protease inhibitor, n (%) 10 (36)* 15 (45) 25 (41)† 0.”
Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial
Ream, M. E., Walsh, E. A., Jacobs, J. M., Taub, C. J., Lippman, M. E., Solle, N. S., Safren, S. A., & Antoni, M. H. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06361-x · Cited by 17
Psychometric Properties of a Symptom Management Self-Efficacy Scale for Women Living with HIV/AIDS
Webel, A. R., & Okonsky, J. G. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.05.013 · Cited by 16
Distress, Sleep Difficulty, and Fatigue in Women Co-Infected With HIV and HPV
Marion, I., Antoni, M. H., Pereira, D. B., Wohlgemuth, W. K., FLETCHER, M. A., Simon, T., & O’Sullivan, M. J. (2009) · Behavioral Sleep Medicine · doi:10.1080/15402000902976721 · Cited by 18
“Adherence to HIV medications was determined using the Adult AIDS Clinical Trials Group Adherence Questionnaire ( Chesney, Ickovics, Chambers, & Gifford, 2000 ).”
Method
Relationship between trauma and high-risk behavior among HIV-positive men who do not have sex with men (MDSM)
Whetten, K., Reif, S., Toth, M., Jain, E., Leserman, J., & Pence, B. W. (2012) · AIDS Care · doi:10.1080/09540121.2012.712665 · Cited by 17
“The SF-36 Physical Health Composite Score to measure physical functioning (McHorney, Ware, Lu, & Sherbourne, 1994) Antiretroviral Medication Adherence was measured using questions created by the Patient Care Committee and the Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trial Group (AAC…”
Method
Assessing adherence in Thai patients taking combination antiretroviral therapy
Kerr, S. J., Avihingsanon, A., Putcharoen, O., Chetchotisakd, P., Layton, M. R., Ubolyam, S., Ruxrungtham, K., Cooper, D. A., Phanuphak, P., & Duncombe, C. J. (2012) · International Journal of STD & AIDS · doi:10.1258/ijsa.2009.009152 · Cited by 17
Feasibility and Acceptability of a Smartphone App for Daily Reports of Substance Use and Antiretroviral Therapy Adherence among HIV-Infected Adults
Przybyla, S., Eliseo‐Arras, R. K., Krawiec, G., Gower, E., & Dermen, K. H. (2016) · AIDS Research and Treatment · doi:10.1155/2016/9510172 · Cited by 20
Design of a Randomized Controlled Trial of Zinc Supplementation to Improve Markers of Mortality and HIV Disease Progression in HIV-positive Drinkers in St. Petersburg, Russia
Gnatienko, N., Freiberg, M., Blokhina, E., Yaroslavtseva, T., Bridden, C., Cheng, D., Chaisson, C. E., Lioznov, D., Bendiks, S., Koerbel, G., et al. (2018) · HIV Clinical Trials · doi:10.1080/15284336.2018.1459344 · Cited by 16
Adherence to antiretroviral therapy in HIV-positive, male intravenous drug users in Pakistan
Ali, B., Nisar, N., & Nawab, F. (2018) · Eastern Mediterranean Health Journal · doi:10.26719/2018.24.3.237 · Cited by 17
“A study conducted in California reported that 11% of the patients missed 1 dose of ART prior to the day of interview, and the most common reason for missing ART was that they simply forgot (21), which is consistent with the finding of our study.”
Maternal and infant antiretroviral therapy adherence among women living with HIV in rural South Africa: a cluster randomised trial of the role of male partner participation on adherence and PMTCT uptake
Jones, D. L., Rodriguez, V. J., Soni, M., Lee, T. K., Weiss, S. M., Ramlagan, S., & Peltzer, K. (2021) · SAHARA-J Journal of Social Aspects of HIV/AIDS · doi:10.1080/17290376.2020.1863854 · Cited by 17
Act Healthy: A Randomized Clinical Trial Evaluating a Behavioral Activation Intervention to Address Substance Use and Medication Adherence Among Low-Income, Black/African American Individuals Living with HIV/AIDS
Magidson, J. F., Belus, J. M., Seitz‐Brown, C. J., Tralka, H. M., Safren, S. A., & Daughters, S. B. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03354-1 · Cited by 17
Initial Validation of the HIV Treatment Regimen Fatigue Scale for Adults Prescribed Antiretroviral Therapy
Claborn, K., Miller, M. B., & Meier, E. (2015) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2015.01.005 · Cited by 17
“Participants (N 5 96) completed a battery of measures assessing: (a) demographic data; (b) treatment adherence over the previous 4 days (AACTG Medication Adherence Questionnaire; Chesney et al., 2000); (c) self-efficacy to adhere to medication regimens (HIV Treatment Adherence Self-Efficacy Scale; Johnson et al.”
Method
Problematic Alcohol Use Among Individuals with HIV: Relations with Everyday Memory Functioning and HIV Symptom Severity
Heinz, A. J., Fogler, K. A. J., Newcomb, M. E., Trafton, J. A., & Bonn‐Miller, M. O. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0602-1 · Cited by 17
Treatment of HIV infection: Swedish recommendations 2009
Josephson, F., Albert, J., Flamholc, L., Gisslén, M., Karlström, O., Moberg, L., Navér, L., Svedhem, V., Svennerholm, B., & Sönnerborg, A. B. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365540903214322 · Cited by 17
“Adherence should be systematically assessed and documented at every patient visit [26,27].”
Background
Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection
Zhang, S., Rust, G. S., Cardarelli, K., Felizzola, J., Fransua, M., & Stringer, H. G. (2015) · AIDS Care · doi:10.1080/09540121.2015.1021745 · Cited by 17
Depressive symptoms and fatigue as mediators of relationship between poor sleep factors and medication adherence in HIV-positive women
Dalmida, S. G., Holstad, M. M., Fox, R., & Delaney, A. M. (2015) · Journal of research in nursing · doi:10.1177/1744987115601464 · Cited by 17
Efficacy of an enhanced linkage to HIV care intervention at improving linkage to HIV care and achieving viral suppression following home-based HIV testing in rural Uganda: study protocol for the Ekkubo/PATH cluster randomized controlled trial
Kiene, S. M., Kalichman, S. C., Sileo, K. M., Menzies, N. A., Naigino, R., Lin, C., Bateganya, M. H., Lule, H., & Wanyenze, R. K. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2537-z · Cited by 17
HIV Transmission Risk Behavior Among HIV-Positive Patients Receiving Antiretroviral Therapy in KwaZulu-Natal, South Africa
Shuper, P. A., Kiene, S. M., Mahlase, G., MacDonald, S. E., Christie, S., Cornman, D. H., Fisher, W. A., Greener, R., Lalloo, U., Pillay, S., et al. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0647-1 · Cited by 17
The Safety, Efficacy, and Pharmacokinetic Profile of a Switch in Antiretroviral Therapy to Saquinavir, Ritonavir, and Atazanavir Alone for 48 Weeks and a Switch in the Saquinavir Formulation
Winston, A., Mallon, P. W. G., Satchell, C. S., MacRae, K., Williams, K. M., Schutz, M., Law, M. G., Cooper, D. A., & Emery, S. (2007) · Clinical Infectious Diseases · doi:10.1086/517507 · Cited by 17
“Safety blood parameters (including serum electrolyte levels, liver function test results, complete blood cell counts, and plasma lipid levels), adherence to treatment (as determined using a previously validated questionnaire [11]), recording of adverse clinical advents, plasma HIV-1 RNA level (assay cutoff value, 50 c…”
Method
Impact of stressful death or divorce in people with HIV: A prospective examination and the buffering effects of religious coping and social support
Ironson, G., Henry, S. M., & Gonzalez, B. D. (2020) · Journal of Health Psychology · doi:10.1177/1359105317726151 · Cited by 16
“Medications were assessed using the interviewer-administered Adult AIDS Clinical Trials Group (AACTG) Adherence Instrument (Chesney et al., 2000), and dummy-coded to reflect whether participants were receiving no antiretroviral medications, combination therapy, or highly-active antiretroviral…”
Method
Where Does Treatment Optimism Fit in? Examining Factors Associated with Consistent Condom Use Among People Receiving Antiretroviral Treatment in Rio de Janeiro, Brazil
Hanif, H., Bastos, F. I., Malta, M., Bertoni, N., WINCH, P. J., & Kerrigan, D. L. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0711-5 · Cited by 16
“A modified AIDS Clinical Trial Group’s (ACTG) questionnaire was used to measure medication adherence [39] AIDS Behav (2014) 18:1945–1954 1947”
Method
Current drug use and lack of HIV virologic suppression: point-of-care urine drug screen versus self-report
Qian, H.-Z., Mitchell, V. J., Bebawy, S. S., Cassell, H. M., Perez, G., McGowan, C. C., Sterling, T. R., Vermund, S. H., D’Aquila, R. T., & Hulgan, T. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-508 · Cited by 15
Differential Associations Between Perceived and Objective Measurement of Distress Tolerance in Relation to Antiretroviral Treatment Adherence and Response Among HIV-Positive Individuals
Oser, M. L., Trafton, J. A., Lejuez, C. W., & Bonn‐Miller, M. O. (2013) · Behavior Therapy · doi:10.1016/j.beth.2013.03.008 · Cited by 16
“The ACTG is a 20-item measure that was developed by the AIDS Clinical Trials Group to assess 20 common symptoms/ART side effects associated with HIV (Chesney et al., 2000).”
Method
Antiretroviral therapy adherence measurement in non-clinical settings in South India
Kleinman, N. J., Manhart, L. E., Mohanraj, R., Kumar, S., Jeyaseelan, L., Rao, D., & Simoni, J. M. (2014) · AIDS Care · doi:10.1080/09540121.2014.946382 · Cited by 16
“The Adult AIDS Clinical Trials Group scale (AACTG; Chesney et al., 2000) and a single-item visual analog scale (VAS; Amico et al., 2006) have both been used in India (Ekstrand, Chandy, Heylen, Steward, & Singh, 2010; Ekstrand et al., 2011; McMahon et al., 2013; Shah et al., 2007; Venkatesh et al.,…”
Method
Impact of a Psychoeducative Intervention on Adherence to HAART among Low-Literacy Patients in a Resource-Limited Setting: The Case of an Arab Country—Morocco
Khachani, I., Harmouche, H., Ammouri, W., Rhoufrani, F., Zerouali, L., Abouqal, R., Tazi, Z. M., Adnaoui, M., Aouni, M., & Maaouni, A. (2011) · Journal of the International Association of Physicians in AIDS Care · doi:10.1177/1545109710397891 · Cited by 16
Maternal priorities for preventive therapy among HIV ‐positive pregnant women before and after delivery in South Africa: a best–worst scaling survey
Kim, H., Dowdy, D. W., Martinson, N. A., Golub, J. E., Bridges, J. F. P., & Hanrahan, C. F. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25143 · Cited by 16
“This questionnaire has been extensively used and validated in other studies [33-36].”
Method
A review of HIV-specific patient-reported measures of perceived barriers to antiretroviral therapy adherence: what themes are they covering?
Engler, K., Toupin, I., Vicente, S., Ahmed, S., & Lebouché, B. (2019) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-019-0124-3 · Cited by 16
Impact and correlates of sub-optimal social support among patients in HIV care
Fredericksen, R. J., Gibbons, L. E., Fitzsimmons, E., Nance, R. M., Schafer, K. R., Batey, D. S., Loo, S. S., Dougherty, S., Mathews, W. C., Christopoulos, K., et al. (2021) · AIDS Care · doi:10.1080/09540121.2020.1853660 · Cited by 17
“…ART using the Self-Rating Scale (Likert scale, very poor to excellent) and a 30-day visual analog scale (0–100% of medication taken in past month) (Chesney et al., 2000; Lu et al., 2008; Simoni et al., 2006); substance use (AUDIT/AUDIT-C for alcohol use, ASSIST for other substances) (Bradley et…”
Method
Polysubstance use and adherence to antiretroviral treatment in the Miami Adult Studies on HIV (MASH) cohort
Degarege, A., Krupp, K., Tamargo, J. A., Martínez, S. S., Campa, A. L., & Baum, M. K. (2021) · AIDS Care · doi:10.1080/09540121.2021.1896660 · Cited by 16
“Responses were recorded in numerical form (Chesney et al., 2000).”
Perinatal Depressive Symptoms, Human Immunodeficiency Virus (HIV) Suppression, and the Underlying Role of Antiretroviral Therapy Adherence: A Longitudinal Mediation Analysis in the IMPAACT P1025 Cohort
Momplaisir, F. M., Hussein, M., Kacanek, D., Brady, K. T., Agwu, A. L., Scott, G. B., TUOMALA, R. E., & Bennett, D. S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab416 · Cited by 17
Poor adherence is a major barrier to the proper treatment of cutaneous leishmaniasis: A case-control field assessment in Iran
Bamorovat, M., Sharifi, I., Afshari, S. A. K., Karamoozian, A., Tahmouresi, A., Heshmatkhah, A., Salarkia, E., Khosravi, A., Parizi, M. H., & Barghi, M. (2022) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2022.11.006 · Cited by 16
“Depression, anxiety, and how individuals succeed in stress are among the most significant forecasters of adherence (Chesney et al., 2000; Murphy et al., 2001; Paterson and Singh, 2001).”
Background
Pilot study examining the efficacy of an electronic intervention to promote HIV medication adherence
Claborn, K., Leffingwell, T. R., Miller, M. B., Meier, E. M., & Stephens, J. R. (2013) · AIDS Care · doi:10.1080/09540121.2013.824534 · Cited by 16
“Patients were eligible for enrollment in the trial if they were (1) infected with HIV, (2) at least 18 years of age, (3) currently prescribed a HAART regimen, and (4) reported adherence 95%.”
BackgroundMethodInfluential
Site Nurse–Initiated Adherence and Symptom Support Telephone Calls for HIV-Positive Individuals Starting Antiretroviral Therapy, ACTG 5031: Substudy of ACTG 384
Robbins, G. K., Testa, M. A., Su, M., Safren, S. A., Morse, G. D., Lammert, S. M., Shafer, R. W., Reynolds, N. R., & Chesney, M. A. (2013) · HIV Clinical Trials · doi:10.1310/hct1405-235 · Cited by 16
Self-citation
Medication Adherence: Tailoring the Analysis to the Data
Saberi, P., Johnson, M. O., McCulloch, C. E., Vittinghoff, E., & Neilands, T. B. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9951-9 · Cited by 16
Outcomes of a Multifaceted Medication Adherence Intervention for HIV-Positive Patients
Dieckhaus, K. D., & Odesina, V. (2007) · AIDS Patient Care and STDs · doi:10.1089/apc.2006.0044 · Cited by 16
“8,19,20 Integration of medication dosing into a patient’s home environment by cueing to recurring lifestyle events such as meal-times, television shows, and bedtime routine is associated with improved adherence.”
Abacavir and tenofovir disoproxil fumarate co-administration results in a nonadditive antiviral effect in HIV-1-infected patients
Goicoechea, M., Jain, S., Bi, L., Kemper, C. A., Daar, E. S., Diamond, C. A., Ha, B., Flaherty, J. F., Sun, S., Richman, D. D., et al. (2010) · AIDS · doi:10.1097/qad.0b013e32833676eb · Cited by 16
“Adherence to study medication was assured by witnessed doses during monotherapy (days 1, 2, 3, 5 and 8) and dual-therapy visits (days 42, 43, 44, 46 and 49) and assessed by standardized self-report for other visits [32].”
Method
Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial
Uusküla, A., Laisaar, K., Raag, M., Lemsalu, L., Lõhmus, L., Rüütel, K., Amico, K. R., Zilmer, K., Aug, T., Kase, K., et al. (2017) · Aids and Behavior · doi:10.1007/s10461-017-1859-6 · Cited by 16
The Relationship Between Efavirenz as Initial Antiretroviral Therapy and Suicidal Thoughts Among HIV-Infected Adults in Routine Care
Bengtson, A. M., Pence, B. W., Mollan, K. R., Edwards, J. K., Moore, R. D., O’Cleirigh, C. M., Eaton, E., Eron, J. J., Kitahata, M. M., Mathews, W. C., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001510 · Cited by 16
Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV
Saloner, R., Grelotti, D. J., Tyree, G. A., Sundermann, E. E., Ma, Q., Letendre, S. L., Heaton, R. K., & Cherner, M. (2019) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002183 · Cited by 18

Authors: Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE
Affiliations: University of California, San Francisco (US)
Yale University (US)
University of California San Diego (US)
The Ohio State University (US)
Indiana University Indianapolis (US)
Johns Hopkins University (US)
ORCID: Chesney, M. A.
Ickovics, J. R.
Gifford, A. L.
Wu, A. W.
Venue: AIDS Care
Publisher: Informa UK Limited
Published: 2000-06
Volume: 12
Issue: 3
Pages: 255-266
ISSN: 0954-0121 (ISSN-L)
1360-0451
DOI: 10.1080/09540120050042891
OpenAlex: W2088423598
Cited by: 1,428
References: 12
Citations by year: 2026: 14 · 2025: 28 · 2024: 29 · 2023: 29 · 2022: 40 · 2021: 53 · 2020: 51 · 2019: 55 · 2018: 61 · 2017: 66 · 2016: 67 · 2015: 76 · 2014: 81 · 2013: 84 · 2012: 74
FWCI: 27.22
Type: journal article
Language: en
Open access: closed
Locations: AIDS Care (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (P50-MH42459, P30MH059037, P50MH042459, P30-MH 59037)
National Institute of Allergy and Infectious Diseases (U01AI-38858, U01AI038858)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: antiretroviral therapy adherence, HIV, self-report questionnaire, medication non-adherence, adherence self-efficacy, alcohol consumption, protease inhibitors, clinical trial participants, questionnaire development
MeSH terms: Adult, Alcohol Drinking, Clinical Trials as Topic, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Patient Compliance, Pilot Projects, Surveys and Questionnaires, Risk Factors, Socioeconomic Factors, HIV Infections, Anti-HIV Agents, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks